Evidence map›Paper›PMID 30992014›Full record

ArticleHealth research policy and systems2019

Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis.

Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Alireza Rezvanian, Nicola Luigi Bragazzi, Soudabeh Vatankhah

Abstract read
In one paragraph

Article in Health research policy and systems, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Hepatitis B vaccination in Iran: Historical policies and programs.Journal of preventive medicine and hygiene · 2022
    Article
  12. Quantitative Evaluation of China's Ecological Protection Compensation Policy Based on PMC Index Model.International journal of environmental research and public health · 2022
    Article
  13. Digital Health Care Industry Ecosystem: Network Analysis.Journal of medical Internet research · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masoud BehzadifarHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hasan Abolghasem GorjiDepartment of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Aziz RezapourHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Alireza RezvanianSchool of Computer Science, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran.
Nicola Luigi BragazziSchool of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Soudabeh VatankhahDepartment of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. vatankhahsoudabeh@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis C virus (HCV) infection is a major public health challenge worldwide. Implementing policies to cope with this challenge requires commitment from all stakeholders at various levels, and all necessary resources should be mobilised. Support for various HCV-related stakeholders can reduce the challenges and obstacles that can be encountered during the programme implementation. The present study aims to identify all stakeholders involved with HCV-related policy-making in Iran at different steps (policy development, implementation and evaluation) and to characterise them in terms of interest, position, power and influence, in order to provide valuable information for appropriate decision-making and design. The present study can also serve as a case study for healthcare systems in other countries.

methodAn approach based on social network analysis was utilised. Data collected included relevant document searches and in-depth interviews to a sample of 18 key informants.

resultsVarious stakeholders were found to be involved with HCV-related policies in Iran. The extent of their participation and support in policy-making varied. Specifically, international agencies had a high interest for HCV-related policy-making, whereas media and members of the private sector were characterised by a medium interest and governmental and non-governmental bodies by a highly variable interest, ranging from low to high, depending on the specific organism. Moreover, media and members of the private sector, non-governmental institutions and international agencies were rated low in terms of position, whereas governmental actors were rated low to high. Media were rated medium in terms of power, whereas international agencies and members of the private sector were respectively rated low to medium and low. Non-governmental actors were rated low, whilst governmental bodies were rated low to high. Finally, media, members of the private sector and international agencies were rated medium in terms of influence, whereas non-governmental and governmental actors were respectively rated low to medium and low to high.

conclusionPolicy-making involves trust, negotiation and integration of the different views of all stakeholders. Social network analysis was critical for identifying stakeholders and showing that, in Iran, involvement in HCV-related policy-making is generally low. This information is of practical implication for policy- and decision-makers regarding the adoption of more favourable and effective strategies.

Indexed as

Delivery of Health CareHealth PolicyPolicy MakingStakeholder ParticipationAdministrative PersonnelDecision MakingDeveloping CountriesGovernmentHepacivirusHepatitis CHumansInternational CooperationIranMass MediaOrganizationsPrivate SectorHCVIranpolicy-makingsocial network analysisstakeholders analysis

Identifiers

PMID30992014
PMCPMC6469134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.